30 Years of Evidence

Take a moment to explore a selection of publications and conference abstracts from around the globe. Find evidence for a wide range of treatment sites including malignant and benign disease, different fractionation schedules and real-time motion synchronization techniques for the CyberKnife® and Radixact®/ TomoTherapy® platforms. We update new papers on a regular basis. See how health professionals are helping to improve patient outcomes.

CyberKnife Based Fractionated Stereotactic Radiotherapy as an Upfront Treatment for Cerebral Arteriovenous Malformation

Lee J, Kim WC, Kim HJ, Park H. | Clin Neurosci.| 2023

Stereotactic Radiosurgery for Sarcoma Metastases to the Brain: A Single-institution Experience

Zamarud A, Park DJ, Dadey DYA, Yoo KH, Marianayagam NJ, Yener U, Szalkowski GA, Pollom E, Soltys S, Chang SD, Meola A. | Neurosurg Focus. | 2023

Lung-heart Toxicity in a Randomized Clinical Trial of Hypofractionated Image Guided Radiation Therapy for Breast Cancer

Van Parijs H, Cecilia-Joseph E, Gorobets O, Storme G, Adriaenssens N, Heyndrickx B, Verschraegen C, Nguyen NP, De Ridder M, Vinh-Hung V | Front Oncol. | 2025

Toxicity of Dose-escalated, Hypofractionated Helical TomoTherapy for Inoperable Thoracic Esophageal Squamous Cell Carcinoma

Zhang SM, Sun J, Pan XO, Zhu WC, Zhou YK | World J Clin Oncol | 2025

Long-term Cardiac Outcomes in Breast Cancer Patients Treated with Helical TomoTherapy: Evaluating the Applicability of 3D-based Dose Constraints for Intensity Modulated Radiation Therapy

Loap P, Uakkas A, Bouziane J, Fourquet A, Kirova Y | Int J Cancer | 2025

Automated Deep Inspiration Breath-Hold (DIBH) in Breast Radiotherapy: A Comprehensive Assessment of the VitalHold System on the Radixact Platform

Retif P, Djibo Sidikou A, Gribelbauer J, Al Salah A, Pfletschinger E, Michel X | Phys Med | 2025

A Dosimetric Comparison of Helical TomoTherapy Treatment Delivery with Real-time Adaption and No Motion Correction

Hindmarsh J, Crowe S, Johnson J, Sengupta C, Walsh J, Dieterich S, Booth J, Keall P | Phys Imaging Radiat Oncol | 2025

Plan Quality Comparison at Five Years in Two Cohorts of Breast Cancer Patients Treated with Helical TomoTherapy

Dicuonzo S, Zerella MA, Zaffaroni M, Vincini MG, Amin K, Ronci G, D’arcangelo M, Rojas DP, Morra A, Gerardi MA, Fodor C, Cambria R, Luraschi R, Cattani F, Veronesi P, De Lorenzi F, Rietjens M, Orecchia R, Leonardi MC, Jereczek-Fossa BA | J Clin Med | 2025

Long-term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image-guided Radiotherapy for Postoperative Prostate Cancer Patients

Mukai Y, Omura M, Minagawa Y, Mase M, Nishikawa Y, Miura I, Hata M | Cancer Diagn Progn | 2025

Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final Analysis

Loap P, Uakkas A, Allali S, Bouziane J, Fourquet A, Kirova Y | Cancers (Basel) | 2025

Rationale, Implementation Considerations, Delineation and Planning Target Objective Recommendations for Volumetric Modulated Arc Therapy and Helical TomoTherapy Total Body Irradiation, Total Marrow Irradiation, Total Marrow and Lymphoid Irradiation and Total Lymphoid Irradiation

Hoeben BAW, Saldi S, Aristei C, Engellau J, Ocanto A, Hiniker SM, Misson-Yates S, Kobyzeva DA, Pazos M, George Mikhaeel N, Rodriguez-Roldan M, Seravalli E, Bosman ME, Han C, Losert C, Engström PE, Fulcheri CPL, Zucchetti C, Ferrer C, Hussein M, Loginova AA, Clark CH, Wong JYC | Radiother Oncol | 2025

Prognostic Analysis of Helical TomoTherapy Stereotactic Body Radiotherapy in Multiple Primary or Second Primary Lung Cancers

Ma J, Xu X, Huang W, Hu Y, Chen G, He J | BMC Cancer | 2025

Verification of Daily Dose Recalculation Accuracy for an Adaptive Radiation Therapy Monitoring Tool in Helical TomoTherapy for Nasopharyngeal Carcinoma

Maneepan Y, Watcharawipha A, Chitapanarux I, Wanwilairat S, Nobnop W | J Appl Clin Med Phys | 2024

Impact of Ground-glass Component on Prognosis in Early-stage Lung Cancer Treated with Stereotactic Body Radiotherapy Via Helical TomoTherapy

Ma J, Fan S, Huang W, Xu X, Hu Y, He J | Radiat Oncol | 2024

Risk Factors for Treatment-related Sensorineural Hearing Loss and Hearing Aid use in Medulloblastoma Patients: An Observational Cohort Study

Troschel FM, Steike DR, Roers J, Kittel C, Siats J, Parfitt R, Hesping AE, Am Zehnhoff-Dinnesen A, Neumann K, Eich HT, Scobioala S | Strahlenther Onkol | 2024